Printer Friendly

Medtech Insight's ''in circulation'' Investment and Partnering Conference to Feature Presentations by Over 35 Emerging Cardiovascular Technology Companies.

NEWPORT BEACH, Calif. -- "in circulation: Strategic Partnering and Investing in Circulatory Medicine" - April 27, 2005 The Hyatt Regency McCormick Place, Chicago, Illinois

Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information and analysis on the medical technology industry, is holding its upcoming "in circulation: Strategic Partnering and Investing in Circulatory Medicine" conference on April 27th, 2005 at the Hyatt Regency McCormick Place in Chicago, Ill. This one-day event will feature presentations by over 35 innovative emerging vascular technology companies presenting to an audience of more than 200 senior executives from the top cardiovascular technology companies, investment firms, and service companies, for purposes of strategic partnering and/or investment. To register, call Medtech Insight at 949-219-0150 (888-290-2225 toll-free in the U.S.), e-mail, or visit the Medtech Insight website at for conference details and registration information.

"In circulation" will be the first specialty-specific investment and partnering conference focusing on early-stage companies developing products for such high-growth segments as interventional cardiology, stroke, peripheral vascular disease, electrophysiology, congestive heart failure, cardiac surgery and cardiovascular disease and diagnosis, and regenerative medicine, among others.

Early-stage companies confirmed to present at the event include: Allvivo Vascular, AzERx, CardiacAssist, Cardiac Output Technologies, Cardiac Power, Cardio3, CardioLa, CHF Technologies, CoAxia, CoolTouch, Direct Flow Medical, Endothelix, HeartSTAT, Hemonix, IDev Technologies, Inovise Medical, Integrated Sensing Systems, Minnow Medical, MiTiHeart, Mitralign, MitralSolutions, Myocor, National Quality Care, Neural Intervention Technologies, NMT Medical, NovoSci, Odicrain, OmniSonics Medical Technologies, Orqis Medical, Percardia, PlaCor, QuantumCor, Transvivo, Vascular Reconditioning, and Vital Sensors (check the Medtech Insight website at for regularly updated event information). The event is arranged in a single-track format, consisting of 10-minute company presentations immediately followed by individual meetings in private breakout rooms.

The "in circulation" audience will include senior management from these top-tier medical technology companies and investment firms, among many others: Abbott Laboratories, ABIOMED, Adams Harkness, Advanced Technology Ventures, Affinity Capital Management, Arrow International, Ascension Health Ventures, Baird Venture Partners, Baxter Healthcare, Boston Scientific, Cardinal Health, COBE Cardiovascular, Cook, Cordis, Datascope, De Novo Ventures, Edwards Lifesciences, Fresenius Medical Care, Guidant, Jeffries & Co. Inc., Johnson & Johnson, Kensey Nash, KeyBanc Capital Markets, Kimberly-Clark, Mallinckrodt Medical, Medtronic, Musculoskeletal Transplant Foundation, Philips Medical Systems, Regeneration Technologies, Roberts Mitani, Roche Diagnostics, Spray Venture Partners, St. Jude Medical, W.L. Gore, and Volant Ventures, and many more.

The program will be kicked off by a keynote presentation by cardiac device entrepreneur Manny Villafana, Chairman and CEO of CABG Medical, Inc., a start-up company developing an artificial coronary artery graft. Mr. Villafana, who will speak on the "Trials and Tribulations of a Biomedical Device Entrepreneur," is bringing over 40 years of medical device industry and product development experience to the "in circulation" stage, including founding the successful companies Cardiac Pacemakers/Guidant, St. Jude Medical, GV Medical, and ATS Medical. He is also co-developer of the St. Jude heart valve, and co-inventor of the first open pivot heart valve from ATS Medical.

"In circulation" will also feature a timely, interactive panel discussion entitled "Turf Wars: Who Will Take Hold of New Technologies?" The session will feature a group of industry expert interventionalist and surgeon panelists, led by the leading cardiovascular clinicians/event co-chairs Michael J. Mack, M.D., Chairman, Board of Directors at The Cardiopulmonary Research Science & Technology Institute and Director of Cardiovascular Services, Director of Transplantation at Medical City Dallas Hospital; Richard Heuser, M.D., Director of Cardiovascular Research at St. Joseph's Hospital & Medical Center, and Clinical Professor of Medicine at University of Arizona, College of Medicine; Donald S. Baim, M.D., Professor of Medicine at Harvard Medical School and Director at the Center for Integration of Medicine and Innovative Technology, Brigham and Women's Hospital; Steven Bailey, M.D., Professor of Medicine and Radiology and Director of Interventional Cardiology at University of Texas Health Science Center at San Antonio; David Brown, M.D., Interventional Cardiologist and Founding Partner of Texas Heart Hospital of the Southwest; and Todd Rosengart, M.D., Owen L. Coon Chair and Head, Division of Cardiothoracic Surgery at Evanston Northwestern Healthcare. The panel will be moderated by David Cassak, Managing Partner at Windhover Information.

Event co-sponsors include Boston Biomedical Associates, Business Wire, Medmarc and The Hartford, Ronald Trahan Associates, The Medtech Group, and Windhover Information.

To register, call Kristy Grimes of Medtech Insight at 480-985-9512, e-mail, or register on the Medtech Insight website, at

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please visit
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 22, 2005
Previous Article:Cypress CFO to Shift to SunPower Subsidiary to Manage IPO; 12-Year Cypress Veteran to Assist Fast-Growing Silicon Solar Cell Business in Its Bid to...
Next Article:Fidelis Updates North Franklin Project ``Archer-Wildlands #1'' Gas Well and Gas Production.

Related Articles
Medtech Insight's Upcoming 'in circulation' Partnering and Investment Meeting to Feature Presentations by over 30 Innovative Privately Held...
More Than 20 Emerging Privately Held Cardiovascular and Interventional Cardiology Companies Already Confirmed to Present at Medtech Insight's ''in...
Medtech Insight Announces ``Investment In Innovation: A Preview of Early-Stage Medical Technology Companies'' Investment and Partnering Conference,...
Medtech Insight's 'in circulation' Partnering and Investment Meeting Featuring Presentations by More Than 35 Early-Stage Cardiovascular and...
Medtech Insight Will Hold its First In3 EUROPE Early-Stage Medical Technology Investment and Partnering Conference on Sept. 20-21 in Brussels,...
36 of the Most Promising Early-Stage Vascular Device Companies will be Featured at Medtech Insight's 'in circulation: Strategic Partnering and...
Boston Biomedical Associates -BBA- To Co-Sponsor Medtech Insight's ''In Circulation'' Conference.
Boston Biomedical Associates to Co-Sponsor Medtech Insight's ``In Circulation'' Conference.
50 Innovative Emerging Medical Technology Companies Seeking Funding and/or Strategic Partnership to Present at Medtech Insight's 'In3 WEST'...
Hear Presentations from Nearly 40 Early-Stage Cardiovascular, Spine/Orthopedics, Biotechnology and Other Emerging Medical Technology Companies from...

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters